The body's master antioxidant, studied for oxidative stress reduction, immune support, liver detoxification, and skin brightening.
Glutathione is a tripeptide (glutamate, cysteine, glycine) and the body's primary endogenous antioxidant. It neutralizes free radicals, supports Phase II liver detoxification, modulates the immune system, and protects mitochondria from oxidative damage. Levels decline with age, illness, and chronic stress.
Glutathione repletion through physician-supervised protocols has been studied for antioxidant support, immune enhancement, and cellular protection. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| Master antioxidant | Neutralizes free radicals, reduces oxidative stress |
| Phase II detoxification | Supports liver detox pathways, neutralizes toxins |
| Immune modulation | Enhances T-cell function, NK cell activity |
| Skin brightening | Inhibits melanin synthesis, supports even skin tone |
| Mitochondrial support | Protects mitochondria from oxidative damage |
| Liver protection | Supports hepatocyte function, heavy metal chelation |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with NAD+ candidates:
Individuals with high oxidative load, chronic illness, or environmental toxin exposure seeking antioxidant support.
Individuals seeking enhanced immune function, reduced inflammation, and pathogen defense support.
Individuals seeking liver support, heavy metal clearance, and Phase II detox pathway optimization.
Individuals targeting melanin regulation, skin luminosity, and oxidative aging reduction.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — From our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility.